Vandetanib: opening a new treatment practice in advanced medullary thyroid carcinoma.
about
Ret function in muscle stem cells points to tyrosine kinase inhibitor therapy for facioscapulohumeral muscular dystrophy.PI3K/Akt/mTOR signaling in medullary thyroid cancer: a promising molecular target for cancer therapy.Management of hereditary medullary thyroid carcinoma.Overexpression of genes involved in miRNA biogenesis in medullary thyroid carcinomas with RET mutation.Novel therapeutic clues in thyroid carcinomas: The role of targeting cancer stem cells.The molecular classification of hereditary endocrine diseases.Vandetanib induces a marked anti-tumor effect and amelioration of ectopic Cushing's syndrome in a medullary thyroid carcinoma patient.Environmental Enrichment Reverses Tyrosine Kinase Inhibitor-Mediated Impairment Through BDNF-TrkB Pathway.Rapid response of hypercortisolism to vandetanib treatment in a patient with advanced medullary thyroid cancer and ectopic Cushing syndrome.
P2860
Q37413081-E0336301-801C-45C6-B20B-1610A2228B84Q38239229-21CCDC94-6DBA-4E59-9D5C-0BD559B894F2Q38721033-9A05163D-0FA5-4E15-AAAD-EC53FDD89D51Q39020838-C9CC2BF3-B391-4A8F-B190-941AAEB65E8EQ39354316-9F56D421-2047-48DC-995E-4BFDF34BF8B4Q41840207-0970F408-5052-4E4F-A632-8D3F00FD2C28Q42374902-752F0E24-D050-4812-9F0E-D17C7A67A885Q47914030-81351294-D199-487B-9B55-223703F64317Q53674570-E6B11293-5B31-4EF1-B48F-FEFC7AD24758
P2860
Vandetanib: opening a new treatment practice in advanced medullary thyroid carcinoma.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Vandetanib: opening a new treatment practice in advanced medullary thyroid carcinoma.
@en
type
label
Vandetanib: opening a new treatment practice in advanced medullary thyroid carcinoma.
@en
prefLabel
Vandetanib: opening a new treatment practice in advanced medullary thyroid carcinoma.
@en
P2093
P2860
P1433
P1476
Vandetanib: opening a new treatment practice in advanced medullary thyroid carcinoma
@en
P2093
Alessandra Paciaroni
Fabiana Trulli
Katia Plasmati
Sebastiano Filetti
P2860
P2888
P304
P356
10.1007/S12020-013-9943-9
P577
2013-04-14T00:00:00Z